Download PDF

Other users also viewed these articles

SEA 2024 Standards for Global Control of Vascular Risk José María Mostaza; Xavier Pintó; Pedro Armario; Luis Masana; José T. Real; Pedro Valdivielso; Teresa Arrobas-Velilla; Ramón Baeza-Trinidad; Pilar Calmarza; Jesús Cebollada; Miguel Civera-Andrés; José I. Cuende Melero; José L. Díaz-Díaz; Javier Espíldora-Hernández; Jacinto Fernández Pardo; Carlos Guijarro; Carles Jericó; Martín Laclaustra; Carlos Lahoz; José López-Miranda; Sergio Martínez-Hervás; Ovidio Muñiz-Grijalvo; José A. Páramo; Vicente Pascual; Juan Pedro-Botet; Pablo Pérez-Martínez; José Puzo;
Clin Investig Arterioscler. 2024;36:133-94
Use and persistence of lipid-lowering therapy in patients with severe hypercholesterolemia: A prospective study María G. Matta; Benjamín Saenz; Laura Schreier; Agustina Corral; Agustina Sarobe; Pablo Corral;
Clin Investig Arterioscler. 2021;33:308-13
Efficacy and safety of PCSK9 inhibitors in real life Antón González-Guerrero; Eugenia Navarrete-Rouco; David Benaiges; Eva Giralt-Steinhauer; Lidia Marcos; Anna Oliveras; Lluis Recasens; Juan Pedro-Botet;
Clin Investig Arterioscler. 2025;37: